HSPA9 and breast carcinoma: In this study, by constructing PCDHGB7 knockdown and overexpression models and HSPA9 knockdown breast carcinoma cell models, we confirmed the positive correlation between the PCDHGB7 level and the cell's chemosensitivity to carboplatin.